# FDA Inspection 1031416 - Niagara Pharmaceuticals Inc - September 18, 2017

Source: https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/66c14af1-385f-46bf-b8c7-860b8a30d1db
Source feed: FDA_Inspections

> FDA Inspection 1031416 for Niagara Pharmaceuticals Inc on September 18, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031416
- Company Name: Niagara Pharmaceuticals Inc
- Inspection Date: 2017-09-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1167881 - 2022-04-25](https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/ab045d3c-45f7-4c1d-86c2-6d21f4cb8a72)
- [FDA Inspection 1117142 - 2020-02-07](https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/dbc973f2-edee-4f9c-a795-0718e8a091a2)
- [FDA Inspection 975165 - 2016-05-16](https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/f61269f4-f899-41b8-af60-b152cb8fdc24)
- [FDA Inspection 883362 - 2014-05-14](https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/ada9f766-8f84-4af9-a214-22cbe3afb015)
- [FDA Inspection 694739 - 2010-09-08](https://www.globalkeysolutions.net/records/fda_inspections/niagara-pharmaceuticals-inc/1be4e2a6-0c70-4f4d-a97c-44bc12d6cab5)

Company: https://www.globalkeysolutions.net/companies/niagara-pharmaceuticals-inc/86d1fc76-da98-4df3-bf23-bed8075fdd53

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c